Literature DB >> 16120188

Circulating surfactant protein-B levels increase acutely in response to exercise-induced left ventricular dysfunction.

Carmine G De Pasquale1, Leonard F Arnolda, Ian R Doyle, Phillip E Aylward, Andrew E Russell, Andrew D Bersten.   

Abstract

1. As a result of its enormous surface area and necessary thinness for gas exchange, the alveolocapillary barrier is vulnerable to mechanical disruption from raised pulmonary microvascular pressure (Pmv). 2. Because surfactant protein-B (SP-B) leaks into the blood stream from the alveoli in response to alveolocapillary barrier damage and exercise leads to increased Pmv, we sought to determine whether exercise results in increased plasma SP-B. Moreover, in the setting of exercise-induced left ventricular dysfunction, the consequent increase in left heart filling pressure and, therefore, P(mv) would be expected to further increase plasma SP-B levels. 3. Twenty consecutive subjects referred for treadmill exercise stress echocardiography (ESE) had venous blood sampled immediately before and after ESE for batch atrial natriuretic peptide (ANP) and SP-B assay. Echocardiographic measures of pulmonary haemodynamics (pulmonary artery flow acceleration time (pafAT) and right ventricular outflow tract velocity time integral (rVTI)) were also taken pre- and post-exercise. 4. Although circulating ANP levels increased following exercise (P < 0.001), there was no change in circulating SP-B levels in the entire cohort. 5. Ten subjects had a positive ESE for ventricular dysfunction. Although circulating ANP was increased post-exercise in both the negative and positive ESE groups (P < 0.05 and P < 0.01, respectively), circulating SP-B only increased post-exercise in the positive ESE group (P < 0.05). Echocardiographic parameters supported an increment in P(mv) in the cohort with exercise-induced left ventricular dysfunction because this group had an increase in pafAT (P < 0.05; reflecting pulmonary artery pressure) and no change in rVTI. 6. Physical exertion associated with a Bruce protocol ESE is insufficient to increase circulating SP-B, despite evidence of increased left atrial and pulmonary vascular pressure. However, in the setting of exercise-induced myocardial dysfunction, there is a detectable increase in circulating SP-B. 7. The exaggerated increase in pulmonary vascular pressure in exercise-induced myocardial dysfunction may result in increased SP-B leakage from the alveoli into the circulation by altering the integrity of the alveolocapillary barrier to protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120188     DOI: 10.1111/j.0305-1870.2005.04241.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

Review 1.  Biomarkers in acute heart failure--state of the art.

Authors:  Alan S Maisel; Rajiv Choudhary
Journal:  Nat Rev Cardiol       Date:  2012-05-01       Impact factor: 32.419

Review 2.  Lung morphology and surfactant function in cardiogenic pulmonary edema: a narrative review.

Authors:  Kenneth Nugent; Logan Dobbe; Rubayat Rahman; Mohamed Elmassry; Pablo Paz
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

3.  Involvement of the atrial natriuretic peptide in cardiovascular pathophysiology and its relationship with exercise.

Authors:  Júlio C de Almeida; Clodoaldo L Alves; Luiz Carlos de Abreu; Monica A Sato; Fernando L Fonseca; Carlos B de Mello Monteiro; Luiz Carlos M Vanderlei; Hugo Macedo; Carlos M Tavares; Dafne Herrero; Luciano Mr Rodrigues; Vitor E Valenti
Journal:  Int Arch Med       Date:  2012-02-07

4.  Fetal and neonatal samples of a precursor surfactant protein B inversely related to gestational age.

Authors:  Christoph Czernik; Gerd Schmalisch; Christoph Bührer; Hans Proquitté
Journal:  BMC Pediatr       Date:  2013-10-10       Impact factor: 2.125

5.  Surfactant-derived proteins as markers of alveolar membrane damage in heart failure.

Authors:  Paola Gargiulo; Cristina Banfi; Stefania Ghilardi; Damiano Magrì; Marta Giovannardi; Alice Bonomi; Elisabetta Salvioni; Elisa Battaia; Pasquale Perrone Filardi; Elena Tremoli; Piergiuseppe Agostoni
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.